Age and prognosis in patients with pancreatic cancer: a population-based study

References

• Latenstein AEJ, van der Geest LGM, Bonsing BA, et al. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Eur J Cancer. 2020;125:83–93.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer. 2002;2(12):897–909.
   PubMed Web of Science ®Google Scholar
• Carioli G, Malvezzi M, Bertuccio P, et al. European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer. Ann Oncol. 2021;32(4):478–487.
   PubMed Web of Science ®Google Scholar
• Saad AM, Turk T, Al-Husseini MJ, et al. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer. 2018;18(1):688.
   PubMed Web of Science ®Google Scholar
• Raimondi S, Maisonneuve P, Lohr JM, et al. Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors. Cancer Epidemiol Biomarkers Prev. 2007;16(9):1894–1897.
   PubMed Web of Science ®Google Scholar
• Latenstein AEJ, Mackay TM, Creemers GJ, et al. Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis. Acta Oncol. 2020;59(6):705–712.
   PubMed Web of Science ®Google Scholar
• Brada LJH, Walma MS, van Dam RM, et al. The treatment and survival of elderly patients with locally advanced pancreatic cancer: a post-hoc analysis of a multicenter registry. Pancreatology. 2021;21(1):163–169.
   PubMed Web of Science ®Google Scholar
• van der Geest LG, Besselink MG, van Gestel YR, et al. Pancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in The Netherlands. Acta Oncol. 2016;55(3):278–285.
   PubMed Web of Science ®Google Scholar
• Ordonez JE, Hester CA, Zhu H, et al. Clinicopathologic features and outcomes of early-onset pancreatic adenocarcinoma in the United States. Ann Surg Oncol. 2020;27(6):1997–2006.
   PubMed Web of Science ®Google Scholar
• Eguchi H, Yamaue H, Unno M, et al. Clinicopathological characteristics of young patients with pancreatic cancer: an analysis of data from pancreatic cancer registry of Japan pancreas society. Pancreas. 2016;45(10):1411–1417.
   PubMed Web of Science ®Google Scholar
• Alese OB, Jiang R, Shaib W, et al. Young adults with pancreatic cancer: national trends in treatment and outcomes. Pancreas. 2020;49(3):341–354.
   PubMed Web of Science ®Google Scholar
• Goksu SY, Kazmi SMA, Sanford NN, et al. Distinct clinical characteristics of young-onset pancreatic cancer patients. J Clin Oncol. 2020;38(4_suppl):674.
   PubMed Web of Science ®Google Scholar
• Ben-Aharon I, Elkabets M, Pelossof R, et al. Genomic landscape of pancreatic adenocarcinoma in younger versus older patients: does age matter? Clin Cancer Res. 2019;25(7):2185–2193.
   PubMed Web of Science ®Google Scholar
• Heining C, Horak P, Uhrig S, et al. NRG1 fusions in KRAS wild-type pancreatic cancer. Cancer Discov. 2018;8(9):1087–1095.
   PubMed Web of Science ®Google Scholar
• Singhi AD, George B, Greenbowe JR, et al. Real-time targeted genome profile analysis of pancreatic ductal adenocarcinomas identifies genetic alterations that might be targeted with existing drugs or used as biomarkers. Gastroenterology. 2019;156(8):2242–2253.e2244.
   PubMed Web of Science ®Google Scholar
• Kim SY, Weinberg L, Christophi C, et al. The outcomes of pancreaticoduodenectomy in patients aged 80 or older: a systematic review and meta-analysis. HPB. 2017;19(6):475–482.
   PubMed Web of Science ®Google Scholar
• Tamirisa NP, Parmar AD, Vargas GM, et al. Relative contributions of complications and failure to rescue on mortality in older patients undergoing pancreatectomy. Ann Surg. 2016;263(2):385–391.
   PubMed Web of Science ®Google Scholar
• Strijker M, Mackay TM, Bonsing BA, et al. Establishing and coordinating a nationwide multidisciplinary study group: Lessons learned by the Dutch Pancreatic Cancer Group. Ann Surg. 2020;271(4):e102–e104.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457.
   PubMed Web of Science ®Google Scholar
• Varghese AM, Singh I, Singh R, et al. Early-onset pancreas cancer: clinical descriptors, genomics, and outcomes. J Natl Cancer Inst. 2021;113(9):1194–1202.
   PubMedGoogle Scholar
• Yeo H, Betel D, Abelson JS, et al. Early-onset colorectal cancer is distinct from traditional colorectal cancer. Clin Colorectal Cancer. 2017;16(4):293–299.e296.
   PubMed Web of Science ®Google Scholar
• Fairley TL, Cardinez CJ, Martin J, et al. Colorectal cancer in U.S. adults younger than 50 years of age, 1998–2001. Cancer. 2006;107(5 Suppl):1153–1161.
   PubMed Web of Science ®Google Scholar
• Murphy KM, Brune KA, Griffin C, et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res. 2002;62(13):3789–3793.
   PubMed Web of Science ®Google Scholar
• Zhen DB, Rabe KG, Gallinger S, et al. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med. 2015;17(7):569–577.
   PubMed Web of Science ®Google Scholar
• Ansari D, Althini C, Ohlsson H, et al. Early-onset pancreatic cancer: a population-based study using the SEER registry. Langenbecks Arch Surg. 2019;404(5):565–571.
   PubMed Web of Science ®Google Scholar
• Fest J, Ruiter R, van Rooij FJ, et al. Underestimation of pancreatic cancer in the national cancer registry – reconsidering the incidence and survival rates. Eur J Cancer. 2017;72:186–191.
   PubMed Web of Science ®Google Scholar